Sunshine Biopharma's Stock Scorches with Promising mRNA Molecules for Cancer

Sunshine Biopharma, Inc announced this week that its novel-formulation mRNA molecules induce cancer cell death in cell cultures.

Explosions in mRNA research have led to groundbreaking discoveries in recent years, with many companies banking on the potential seen in clinical spaces. As a result of the announcement, shares of the company’s stock bounded upwards to the top of trending charts, possibly a reflection of investor interest in mRNA.